PAR 4.17% 23.0¢ paradigm biopharmaceuticals limited..

Sass, page-60

  1. 15 Posts.
    lightbulb Created with Sketch. 2
    few issues that come to mind:
    -CR for his insto mates at discounted share price
    -material slip ups in investor presentations (which the market had not yet been informed)
    -changes in key management personnel which were casually slipped to the market
    -quarterly targets in their control are not always met
    -taking on additional responsibility - board member of another listed (not necessarily a bad thing)

    im not saying it’s all his fault but it’s hard to not argue why there needs to be a segregation of the roles - PR can’t operate the ship and act in the shareholders best interest, that is clear
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.0¢
Change
-0.010(4.17%)
Mkt cap ! $80.48M
Open High Low Value Volume
25.0¢ 25.0¢ 22.5¢ $167.1K 714.6K

Buyers (Bids)

No. Vol. Price($)
8 120730 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.0¢ 49999 1
View Market Depth
Last trade - 16.10pm 18/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.